Skip to main content
LLY
NYSE Life Sciences

Lilly's Foundayo Grabs 30%+ of New US Oral Obesity Patients, Closing Gap on Novo

Tom Rudovsky · Reported by Reuters
More coverage: Pharmaceutical Stocks · Healthcare
Sentiment info
Positive
Importance info
8
Price
$1,138.8
Mkt Cap
$1.072T
52W Low
$712.05
52W High
$1,292.65
52W Position info
60% above low
Off High info
12% below high
Rel. Volume info
0.8× avg
Market data snapshot near publication time

LLY sits 60% above its 52-week low of $712.05.

Summary

Lilly disclosed that Foundayo, its oral obesity drug, has captured over 30% of new US patients in the oral weight-loss market, a significant gain from Novo Nordisk's earlier 90% share estimate in August. This indicates rapid adoption and competitive momentum in a market expected to exceed $100B annually in the US by 2030. The news also highlights Zepbound's strong uptake in the Medicare pilot, with 60-70% of enrollees being new to treatment. Investors are closely watching oral GLP-1 dynamics as they could expand the addressable market beyond injection-averse patients. The disclosure comes ahead of potential regulatory submissions for retatrutide, Lilly's next-gen obesity drug, and follows a strong Q2 with 48% revenue growth.

At the time of this announcement, LLY was trading at $1,138.80 on NYSE in the Life Sciences sector, with a market capitalization of approximately $1.1T. The 52-week trading range was $712.05 to $1,292.65. This news item was assessed with positive market sentiment and an importance score of 8 out of 10. Source: Reuters.


Price Chart

Share this article

Copied!

LLY - Latest Insights

LLY
Nov 18, 2026, 3:04 PM EST
Source: Seeking Alpha
Importance Score:
7
Price at Filing: $1,381.18
Real-time Price: $1,348.06 info
Change: -$33.12 (-2%) info
Market Cap: $1.267T info
LLY
Nov 17, 2026, 11:18 AM EST
Source: Seeking Alpha
Importance Score:
7
Price at Filing: $1,416.23
Real-time Price: $1,348.06 info
Change: -$68.17 (-5%) info
Market Cap: $1.267T info
LLY
Nov 16, 2026, 6:52 AM EST
Source: Reuters
Importance Score:
7
Price at Filing: $1,455.36
Real-time Price: $1,348.06 info
Change: -$107.30 (-7%) info
Market Cap: $1.267T info
LLY
Nov 12, 2026, 8:30 AM EST
Source: Benzinga
Importance Score:
7
Price at Filing: $1,452.70
Real-time Price: $1,348.06 info
Change: -$104.64 (-7%) info
Market Cap: $1.267T info
LLY
Nov 12, 2026, 3:00 AM EST
Source: Wiseek News
Importance Score:
8
Price at Filing: $1,447.85
Real-time Price: $1,348.06 info
Change: -$99.79 (-7%) info
Market Cap: $1.267T info